(1)
EARLY DETERMINATION RISKS OF ATHEROSCLEROSIS IN THE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE. ijms 2025, 5 (12), 1019-1023. https://doi.org/10.55640/.